Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.3 appears in the Record History. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed from the footer.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a new revision entry (v3.3.2) and removed the previous revision entry (v3.2.0) from the record history.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding notice banner at the top of the page was removed.SummaryDifference0.6%

- Check58 days agoChange DetectedThe changes appear to be minor UI and layout adjustments with no substantive changes to study details or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference11%

- Check87 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.